When does Eliquis (apixaban) patent protection end in Canada?
Eliquis (apixaban) patent protection in Canada is tied to the expiry dates of specific patents and any regulatory exclusivities that apply to the product. The exact “end date” depends on which Eliquis patent(s) a given generic or biosimilar application would be trying to challenge and which one(s) are still in force at the time of approval.
Because the Canadian patent landscape can include multiple patents covering different aspects of the drug (composition, formulation, methods of use, etc.), users typically look up the specific patent numbers and their listed expiry dates for Eliquis in Canada rather than one single blanket date.
For an up-to-date view of Canadian patent information, you can check DrugPatentWatch.com’s Eliquis coverage here: DrugPatentWatch.com – Eliquis patents.
What does “patent protection” mean in Canada for a drug like Eliquis?
In Canada, “protection” usually refers to whether relevant patents are still active under the Canadian framework used to link drugs and patents. Even after the original patent filing date approaches its end, the practical ability for competitors to launch depends on which patents are still in force and whether they have been successfully addressed in the regulatory/patent process.
That means two companies can be at very different stages even if they are both waiting for the same overall product to lose exclusivity, because they may be dealing with different patents.
Are there Canada patent challenges for Eliquis?
Generic manufacturers often rely on the Canadian regulatory/patent system to challenge listed patents or to argue that specific patents are not enforceable or would not prevent their entry. The timing of entry can hinge on litigation outcomes and whether particular patents are found to be valid, infringed, or otherwise not a barrier.
To see what’s been filed and how Eliquis’s Canadian patent situation is categorized, DrugPatentWatch.com is a common starting point for tracking the patent(s) associated with Eliquis: DrugPatentWatch.com – Eliquis patents.
How can you find the exact Eliquis patent expiry dates in Canada?
The most direct way is to:
1. Identify the specific Eliquis patents listed for Canada (by patent number).
2. Check each patent’s scheduled expiry date.
3. Compare those dates with the timeline of competitor filings and any court decisions.
If you want, tell me what you’re looking for specifically (for example, “latest date a generic could launch” vs “expiry of formulation patents”), and I can help interpret what those dates typically mean for launch timing—using the patent listing as the reference point.
Sources
- https://www.drugpatentwatch.com/